当前位置:首页 - 行情中心 - 傲农生物(603363) - 财务分析 - 利润表

傲农生物

(603363)

  

流通市值:42.26亿  总市值:49.87亿
流通股本:7.37亿   总股本:8.70亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入15,176,655,806.2910,066,629,131.814,817,861,444.3421,613,039,521.91
营业收入15,176,655,806.2910,066,629,131.814,817,861,444.3421,613,039,521.91
二、营业总成本16,785,291,086.6611,065,128,263.245,132,874,635.3922,475,331,354.43
营业成本15,510,008,060.7710,224,557,555.64,718,079,586.3820,664,798,615.34
税金及附加27,351,759.3618,251,146.618,881,188.6640,047,677.39
销售费用269,811,903.96179,813,581.9886,407,751.04412,695,962.05
管理费用498,399,740.72312,215,727.07148,714,081.85663,642,336.84
研发费用113,451,727.4982,009,310.2847,317,920.67161,672,983.72
财务费用366,267,894.36248,280,941.7123,474,106.79532,473,779.09
其中:利息费用355,796,330.67242,081,357.64119,161,788.41525,817,110.53
其中:利息收入2,078,167.691,675,644.141,202,320.795,943,867.67
加:公允价值变动收益1,757,389.161,757,389.160-105,324,370.85
加:投资收益42,318,264.3341,511,976.6536,750,675.31-14,440,449.26
资产处置收益-2,254,683.924,491,061.441,097,657.312,555,018.49
资产减值损失(新)-72,142,553.84-71,463,439.52--330,235,546.25
信用减值损失(新)-41,853,385.56-30,572,060.86-19,814,831.72-74,857,694.88
其他收益90,588,450.4332,289,808.2817,023,247.0273,197,114.55
营业利润平衡项目0000
四、营业利润-1,590,221,799.77-1,020,484,396.28-279,956,443.13-1,311,397,760.72
加:营业外收入66,794,305.9944,910,441.6530,009,628.2261,579,904.12
减:营业外支出22,554,054.2510,584,1462,098,049.4745,217,396.23
利润总额平衡项目0000
五、利润总额-1,545,981,548.03-986,158,100.63-252,044,864.38-1,295,035,252.83
减:所得税费用-12,489,374.86-7,052,428.53-1,580,295.25-68,084,599.41
六、净利润-1,533,492,173.17-979,105,672.1-250,464,569.13-1,226,950,653.42
持续经营净利润-1,533,492,173.17-979,105,672.1-250,464,569.13-1,226,950,653.42
归属于母公司股东的净利润-1,289,887,940.75-809,323,427.02-179,712,567.24-1,039,026,342.02
少数股东损益-243,604,232.42-169,782,245.08-70,752,001.89-187,924,311.4
(一)基本每股收益-1.49-0.93-0.21-1.34
(二)稀释每股收益-1.49-0.93-0.21-1.34
八、其他综合收益-458,731.44-467,254.48-357,359.84-3,836,126.3
归属于母公司股东的其他综合收益-458,731.44-467,254.48-357,359.84-3,836,126.3
九、综合收益总额-1,533,950,904.61-979,572,926.58-250,821,928.97-1,230,786,779.72
归属于母公司股东的综合收益总额-1,290,346,672.19-809,790,681.5-180,069,927.08-1,042,862,468.32
归属于少数股东的综合收益总额-243,604,232.42-169,782,245.08-70,752,001.89-187,924,311.4
公告日期2023-10-282023-08-312023-04-292023-04-29
审计意见(境内)标准无保留意见
TOP↑